These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2343468)

  • 1. IgG subclass distributions of anti-horse serum antibodies and natural venom-antibodies produced in response to antivenom injection or snake bite in humans.
    Ameno S; Ameno K; Fuke C; Kiryu T; Ijiri I
    Toxicon; 1990; 28(3):347-50. PubMed ID: 2343468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human heterophilic antibodies against equine immunoglobulins: assessment of their role in the early adverse reactions to antivenom administration.
    León G; Segura A; Herrera M; Otero R; França FO; Barbaro KC; Cardoso JL; Wen FH; de Medeiros CR; Prado JC; Malaque CM; Lomonte B; Gutiérrez JM
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1115-9. PubMed ID: 18561967
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Snake venoms in science and clinical medicine. 2. Applied immunology in snake venom research.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(6):741-4. PubMed ID: 2617643
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of venom-antivenom (VAV) immunocomplexes in vitro as a measure of antivenom efficacy.
    O'Leary MA; Isbister GK
    Toxicon; 2014 Jan; 77():125-32. PubMed ID: 24252422
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human anti-snake venom IgG antibodies in a previously bitten snake-handler, but no protection against local envenoming.
    Isbister GK; Halkidis L; O'Leary MA; Whitaker R; Cullen P; Mulcahy R; Bonnin R; Brown SG
    Toxicon; 2010; 55(2-3):646-9. PubMed ID: 19647759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthetic biology tackles global antivenom shortage.
    Arnold C
    Nature; 2016 Apr; 532(7599):292. PubMed ID: 27111610
    [No Abstract]   [Full Text] [Related]  

  • 7. Anti-human erythrocyte antibodies in horse-derived antivenoms used in the treatment of snakebite envenomations.
    León G; Rodríguez MA; Rucavado A; Lomonte B; Gutiérrez JM
    Biologicals; 2007 Mar; 35(1):5-11. PubMed ID: 16490363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New techniques in antivenom production and active immunization against snake venoms.
    Theakston RD
    Trans R Soc Trop Med Hyg; 1989; 83(4):433-5. PubMed ID: 2694474
    [No Abstract]   [Full Text] [Related]  

  • 9. Humoral immune responses to venom and antivenom of patients bitten by Bothrops snakes.
    Morais V; Berasain P; Ifrán S; Carreira S; Tortorella MN; Negrín A; Massaldi H
    Toxicon; 2012 Feb; 59(2):315-9. PubMed ID: 22206812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of camelid IgG for antivenom development: Immunoreactivity and preclinical neutralisation of venom-induced pathology by IgG subclasses, and the effect of heat treatment.
    Cook DA; Samarasekara CL; Wagstaff SC; Kinne J; Wernery U; Harrison RA
    Toxicon; 2010 Sep; 56(4):596-603. PubMed ID: 20547172
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Snake antivenom: Challenges and alternate approaches.
    Alangode A; Rajan K; Nair BG
    Biochem Pharmacol; 2020 Nov; 181():114135. PubMed ID: 32628928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetic-pharmacodynamic relationships of immunoglobulin therapy for envenomation.
    Gutiérrez JM; León G; Lomonte B
    Clin Pharmacokinet; 2003; 42(8):721-41. PubMed ID: 12846594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental manufacture of equine antivenom against yamakagashi (Rhabdophis tigrinus).
    Morokuma K; Kobori N; Fukuda T; Uchida T; Sakai A; Toriba M; Ohkuma K; Nakai K; Kurata T; Takahashi M
    Jpn J Infect Dis; 2011; 64(5):397-402. PubMed ID: 21937821
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The humoral immune response induced by snake venom toxins.
    da Silva WD; Tambourgi DV
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):343-57. PubMed ID: 21824082
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design of a new therapy to treat snake envenomation.
    Shahidi Bonjar L
    Drug Des Devel Ther; 2014; 8():819-25. PubMed ID: 24971000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune response towards snake venoms.
    León G; Sánchez L; Hernández A; Villalta M; Herrera M; Segura A; Estrada R; Gutiérrez JM
    Inflamm Allergy Drug Targets; 2011 Oct; 10(5):381-98. PubMed ID: 21824081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pan-African polyspecific antivenom produced by caprylic acid purification of horse IgG: an alternative to the antivenom crisis in Africa.
    Gutiérrez JM; Rojas E; Quesada L; León G; Núñez J; Laing GD; Sasa M; Renjifo JM; Nasidi A; Warrell DA; Theakston RD; Rojas G
    Trans R Soc Trop Med Hyg; 2005 Jun; 99(6):468-75. PubMed ID: 15837359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of health status of horses immunized with snake venom and montanide adjuvants, IMS 3012 (nanoparticle), ISA 206 and ISA 35 (emulsion based) during polyvalent snake antivenom production: hematological and biochemical assessment.
    Waghmare AB; Salvi NC; Deopurkar RL; Shenoy PA; Sonpetkar JM
    Toxicon; 2014 May; 82():83-92. PubMed ID: 24582735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Equine IgG Antivenoms against Major Snake Groups in Mozambique.
    Guidolin FR; Caricati CP; Marcelino JR; da Silva WD
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004325. PubMed ID: 26730709
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Venoms, antivenoms and immunotherapy.
    Chippaux JP; Goyffon M
    Toxicon; 1998 Jun; 36(6):823-46. PubMed ID: 9663690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.